Gestational Diabetes Can Increase CVD Risk
Jul 27, 2021
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Shalonda Kimble, PharmD Candidate, South College School of Pharmacy; Oluwatayo Ishola, PharmD. Candidate, South College, School of Pharmacy; Macrina Ghali, PharmD Candidate 2021, Florida A&M University, College of Pharmacy and Pharmaceutical Sciences
GD history is linked with coronary artery calcification (CAC) in women, an indicator of atherosclerotic CVD, and a predictor of CVD clinical events.
Gestational diabetes (GD) is a significant risk factor for cardiovascular disease, leading to early-onset and an increased risk of type 2 diabetes. It is unknown whether achieving normoglycemia will mitigate the excess risk of CVD associated with GD history. This study aimed to assess GD history related to coronary artery calcification (CAC) in women. Confirmation is unclear about whether GD history increases CVD risk separate from T2D diagnosis. Although it may seem that maintaining normoglycemic levels reduces CVD risk, women with a history of GD who did not advance to T2D had a 30% to 56% higher CVD risk based on a pooled risk estimate from a meta-analysis. According to previous studies, the risk is still present regardless of glycemic levels post-pregnancy. This analysis evaluated GD history's relationship across the reproductive years to the presence of coronary artery calcium in women during midlife, a strong predictor of atherosclerotic CVD (ASCVD)....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.